Fishbane Steven, Larson Kristin, VanBuskirk Suzann
Winthrop-University Hospital, Mineola, NY, USA.
Nephrol Nurs J. 2008 Sep-Oct;35(5):493-502.
One of the challenges encountered by the nephrology nursing community is how to appropriately stabilize hemoglobin (Hb) levels. Recently, this issue has taken center stage in the anemia management environment, stemming from reports that the majority of patients on hemodialysis are not routinely maintained in an Hb target range of 11 to 12 g/dL and that Hb variability is associated with adverse outcomes. This article will help nephrology nurses better understand the balance between intravenous iron and erythropoiesis-stimulating agents to stabilize Hib levels.
肾脏病护理界面临的挑战之一是如何适当地稳定血红蛋白（Hb）水平。最近，这个问题在贫血管理领域成为了焦点，原因是有报告称，大多数接受血液透析的患者并未常规维持在Hb目标范围11至12 g/dL，且Hb变异性与不良后果相关。本文将帮助肾脏病护士更好地理解静脉铁剂和促红细胞生成素之间的平衡，以稳定Hb水平。
